{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T11:19:11Z","timestamp":1785842351864,"version":"3.56.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.ygyno.2017.05.018","type":"journal-article","created":{"date-parts":[[2017,5,17]],"date-time":"2017-05-17T15:00:43Z","timestamp":1495033243000},"page":"314-318","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Analysis of full coding sequence of the TP53 gene in invasive vulvar cancers: Implications for therapy"],"prefix":"10.1016","volume":"146","author":[{"given":"Karl","family":"Kashofer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sigrid","family":"Regauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2017.05.018_bb0005","series-title":"World Health Organisation, Classification of Tumours of the Female Genital Tract","first-page":"232","article-title":"Tumours of the vulva. Epithelial tumours","author":"Crum","year":"2014"},{"issue":"4","key":"10.1016\/j.ygyno.2017.05.018_bb0010","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.jaad.2014.05.057","article-title":"Vulvar cancers in women with vulvar lichen planus: a clinicopathological study","volume":"71","author":"Regauer","year":"2014","journal-title":"J. Am. Acad. Dermatol."},{"issue":"6","key":"10.1016\/j.ygyno.2017.05.018_bb0015","first-page":"1655","article-title":"Carcinoma of the vulva: HPV and p53 mutations","volume":"9","author":"Lee","year":"1994","journal-title":"Oncogene"},{"issue":"1A","key":"10.1016\/j.ygyno.2017.05.018_bb0020","first-page":"177","article-title":"The state of the p53 gene in human papillomavirus (HPV)-positive and HPV-negative genital precancer lesions and carcinomas as determined by single-strand conformation polymorphism analysis and sequencing","volume":"14","author":"Kurvinen","year":"1994","journal-title":"Anticancer Res."},{"issue":"1","key":"10.1016\/j.ygyno.2017.05.018_bb0025","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1006\/gyno.2000.5739","article-title":"Allelic imbalance in lichen sclerosus, hyperplasia, and intraepithelial neoplasia of the vulva","volume":"77","author":"Pinto","year":"2000","journal-title":"Gynecol. Oncol."},{"issue":"5","key":"10.1016\/j.ygyno.2017.05.018_bb0030","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/PGP.0b013e3182184c7a","article-title":"Role of TP53 mutations in vulvar carcinomas","volume":"30","author":"Choschzick","year":"2011","journal-title":"Int. J. Gynecol. Pathol."},{"issue":"4","key":"10.1016\/j.ygyno.2017.05.018_bb0035","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1097\/IGC.0000000000000975","article-title":"European Society of Gynaecological Oncology guidelines for the management of patients with vulvar cancer","volume":"27","author":"Oonk","year":"2017","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"19","key":"10.1016\/j.ygyno.2017.05.018_bb0040","first-page":"4285","article-title":"Characterization of the p53 tumor suppressor pathway in cell lines of the National Cancer Institute anticancer drug screen and correlations with the growth-inhibitory potency of 123 anticancer agents","volume":"57","author":"O'Connor","year":"1997","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.ygyno.2017.05.018_bb0045","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1172\/JCI6863","article-title":"Disruption of p53 in human cancer cells alters the responses to therapeutic agents","volume":"104","author":"Bunz","year":"1999","journal-title":"J. Clin. Invest."},{"issue":"8","key":"10.1016\/j.ygyno.2017.05.018_bb0050","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1039\/C5PP00251F","article-title":"p53 family members - important messengers in cell death signaling in photodynamic therapy of cancer?","volume":"14","author":"Acedo","year":"2015","journal-title":"Photochem. Photobiol. Sci."},{"issue":"2","key":"10.1016\/j.ygyno.2017.05.018_bb0055","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1158\/1078-0432.CCR-07-1402","article-title":"Inverse relationship between human papillomavirus-16 infection and disruptive p53 gene mutations in squamous cell carcinoma of the head and neck","volume":"14","author":"Westra","year":"2008","journal-title":"Clin. Cancer Res."},{"issue":"12","key":"10.1016\/j.ygyno.2017.05.018_bb0060","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1002\/jcb.25592","article-title":"TP53 mutations in head and neck squamous cell carcinoma and their impact on disease progression and treatment response","volume":"117","author":"Zhou","year":"2016","journal-title":"J. Cell. Biochem."},{"issue":"3","key":"10.1016\/j.ygyno.2017.05.018_bb0065","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/LGT.0000000000000182","article-title":"Biomarkers p16, human papillomavirus and p53 predict recurrence and survival in early stage squamous cell carcinoma of the vulva","volume":"20","author":"Hay","year":"2016","journal-title":"J. Low Genit. Tract. Dis."},{"issue":"8","key":"10.1016\/j.ygyno.2017.05.018_bb0070","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1097\/PAS.0000000000000454","article-title":"Squamous cell carcinoma of the vulva: a subclassification of 97 cases by clinicopathologic, immunohistochemical, and molecular features (p16, p53, and EGFR)","volume":"39","author":"Dong","year":"2015","journal-title":"Am. J. Surg. Pathol."},{"issue":"16","key":"10.1016\/j.ygyno.2017.05.018_bb0075","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkq603","article-title":"ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data","volume":"38","author":"Wang","year":"2010","journal-title":"Nucleic Acids Res."},{"issue":"2","key":"10.1016\/j.ygyno.2017.05.018_bb0080","doi-asserted-by":"crossref","first-page":"80","DOI":"10.4161\/fly.19695","article-title":"A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3","volume":"6","author":"Cingolani","year":"2012","journal-title":"Fly (Austin)"},{"issue":"12","key":"10.1016\/j.ygyno.2017.05.018_bb0085","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1101\/gad.190678.112","article-title":"Mutant p53: one name, many proteins","volume":"26","author":"Freed-Pastor","year":"2012","journal-title":"Genes Dev."},{"issue":"3","key":"10.1016\/j.ygyno.2017.05.018_bb0090","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.ccr.2014.01.021","article-title":"Mutant p53 in cancer: new functions and therapeutic opportunities","volume":"25","author":"Muller","year":"2014","journal-title":"Cancer Cell"},{"issue":"6","key":"10.1016\/j.ygyno.2017.05.018_bb0095","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/humu.22514","article-title":"TP53 mutants in the tower of babel of cancer progression","volume":"35","author":"Bisio","year":"2014","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ygyno.2017.05.018_bb0100","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3389\/fonc.2016.00012","article-title":"Mutant p53 drives cancer by subverting multiple tumor suppression pathways","volume":"6","author":"Haupt","year":"2016","journal-title":"Front. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2017.05.018_bb0105","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a026054","article-title":"Transcriptional regulation by wild-type and cancer-related mutant forms of p53","volume":"7","author":"Pfister","year":"2016","journal-title":"Cold Spring Harb. Perspect. Med"},{"key":"10.1016\/j.ygyno.2017.05.018_bb0110","article-title":"Development of male genital lichen sclerosus in penile reconstruction skin grafts after cancer surgery: an unreported complication","author":"Abdelbaky","year":"2011","journal-title":"BJU Int."},{"key":"10.1016\/j.ygyno.2017.05.018_bb0115","article-title":"Gain of function of mutant p53: R282W on the peak?","volume":"5","author":"Zhang","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.ygyno.2017.05.018_bb0120","article-title":"Mutant p53-R273H gains new function in sustained activation of EGFR signaling via suppressing miR-27a expression","volume":"4","author":"Wang","year":"2013","journal-title":"Cell Death Dis."},{"issue":"6","key":"10.1016\/j.ygyno.2017.05.018_bb0125","doi-asserted-by":"crossref","first-page":"401","DOI":"10.2220\/biomedres.31.401","article-title":"Mutant p53 R248Q but not R248W enhances in vitro invasiveness of human lung cancer NCI-H1299 cells","volume":"31","author":"Yoshikawa","year":"2010","journal-title":"Biomed. Res."},{"issue":"1","key":"10.1016\/j.ygyno.2017.05.018_bb0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1593\/tlo.09250","article-title":"Targeting p53 for novel anticancer therapy","volume":"3","author":"Wang","year":"2010","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.ygyno.2017.05.018_bb0135","article-title":"The p53 family orchestrates the regulation of metabolism: physiological regulation and implications for cancer therapy","author":"Napoli","year":"2016","journal-title":"Br. J. Cancer"},{"issue":"5298","key":"10.1016\/j.ygyno.2017.05.018_bb0140","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1126\/science.275.5298.343","article-title":"An information-intensive approach to the molecular pharmacology of cancer","volume":"275","author":"Weinstein","year":"1997","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.ygyno.2017.05.018_bb0145","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/joim.12336","article-title":"Pharmacological reactivation of p53 as a strategy to treat cancer","volume":"277","author":"Zawacka-Pankau","year":"2015","journal-title":"J. Intern. Med."},{"issue":"5","key":"10.1016\/j.ygyno.2017.05.018_bb0150","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1158\/1541-7786.MCR-10-0534","article-title":"Functional inactivation of endogenous MDM2 and CHIP by HSP90 causes aberrant stabilization of mutant p53 in human cancer cells","volume":"9","author":"Li","year":"2011","journal-title":"Mol. Cancer Res."},{"issue":"14","key":"10.1016\/j.ygyno.2017.05.018_bb0155","doi-asserted-by":"crossref","first-page":"6745","DOI":"10.1158\/0008-5472.CAN-06-4447","article-title":"Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth","volume":"67","author":"Buzzai","year":"2007","journal-title":"Cancer Res."},{"issue":"12","key":"10.1016\/j.ygyno.2017.05.018_bb0160","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17122074","article-title":"p53 as a regulator of lipid metabolism in cancer","volume":"17","author":"Parrales","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"1\u20132","key":"10.1016\/j.ygyno.2017.05.018_bb0165","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.cell.2011.12.017","article-title":"Mutant p53 disrupts mammary tissue architecture via the mevalonate pathway","volume":"148","author":"Freed-Pastor","year":"2012","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.ygyno.2017.05.018_bb0170","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/ncb3435","article-title":"Targeting mutant p53 through the mevalonate pathway","volume":"18","author":"Freed-Pastor","year":"2016","journal-title":"Nat. Cell Biol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825817308727?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825817308727?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,24]],"date-time":"2019-09-24T19:32:11Z","timestamp":1569353531000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825817308727"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S0090825817308727"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2017.05.018","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analysis of full coding sequence of the TP53 gene in invasive vulvar cancers: Implications for therapy","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2017.05.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}